REQUEST A DEMO
Total
USD $0.00
Search more companies

Estudio Rx S.A.S. (Colombia)

Main Activities: Other Ambulatory Health Care Services
Secondary Activities: Diagnostic Imaging Centers
Full name: Estudio Rx S.A.S. Profile Updated: May 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Estudio Rx S.A.S. is an enterprise located in Colombia, with the main office in Cali. The company operates in the Other Ambulatory Health Care Services sector. Estudio Rx S.A.S. was incorporated on July 20, 2016. It currently has a total number of 4 (2024) employees. In its most recent financial highlights, the company reported a net sales revenue drop of 6.14% in 2023. Its’ total assets recorded a growth of 7.57%. The net profit margin of Estudio Rx S.A.S. decreased by 1.42% in 2023.

Headquarters
Cl 5 # 43 - 25
Cali; Valle del Cauca;

Contact Details: Purchase the Estudio Rx S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Estudio Rx S.A.S. report to view the information.
Outstanding Shares:
Purchase the Estudio Rx S.A.S. report to view the information.
Incorporation Date:
July 20, 2016
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Estudio Rx S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-6.14%
Total operating revenue
-6.14%
Net Profit (Loss) for the Period
-14.26%
Total assets
7.57%
Total equity
-12.69%
Net Profit Margin
-1.42%
Return on Equity (ROE)
-0.24%
Quick Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?